Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Butler and Nicholas Thomas.
Christopher Butler
Connection Strength
0.359
Nicholas Thomas
  1. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
    View in: PubMed
    Score: 0.240
  2. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
    View in: PubMed
    Score: 0.060
  3. Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk. BMJ Open. 2021 06 18; 11(6):e046799.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.